Clinical library

Every tool, one focused workspace.

1,329 calculators and references across 60 specialties, with formula confidence shown up front.

✓

6results

Interactive worksheet

THEMIS-PCI Benefit vs Bleeding Algorithm

The audited source currently returns an empty page. This catalog entry is retained for coverage and monitoring, but no clinical content or calculation is asserted.

Interactive worksheet

TRACE Study – Post-MI Heart Failure Risk (TRACE-inspired) Calculator

TRACE Study — Post-MI Heart Failure Risk (explanation and clinical context) This calculator is TRACE-inspired: the original TRAndolapril Cardiac Evaluation (TRACE) was a randomized trial that enrolled patients with reduced left ventricular function soon after myocardial infarction and demonstrated morbidity and mortality benefits of long-term ACE inhibition (trandolapril) in that population. TRACE showed that LV syst

Interactive worksheet

TRANSFORM-HF Mortality Comparison Index

: Explanation and Clinical Context The TRANSFORM-HF Mortality Comparison Index is derived from the TRANSFORM-HF trial (Felker GM, et al., NEJM 2022), which compared torsemide and furosemide in patients hospitalized with heart failure. The trial demonstrated no statistically significant difference in all-cause mortality at 12 months between the two diuretics (26.1% vs 26.2%; HR 1.02, 95% CI 0.89–1.18). This calculator

Interactive worksheet

TRED-HF Recovery Relapse Prediction Model

TRED-HF Recovery / Relapse Prediction — explanation and clinical context The TRED-HF randomized pilot trial examined phased withdrawal of all heart failure pharmacotherapy in carefully selected patients with previously dilated cardiomyopathy who had asymptomatic recovery of left ventricular function (LVEF ≥50%), normalised indexed LV volumes, and low NT-proBNP at baseline; approximately 40–44% of participants relapse

Interactive worksheet

TRUE-AHF Prognostic Classification (experimental prototype)

TRUE-AHF Prognostic Classification — explanation and clinical context This page implements an experimental prognostic classifier inspired by common predictors used in acute heart failure (AHF) prognostic models: advanced age, low systolic blood pressure, tachycardia, elevated BUN/creatinine, hyponatremia, elevated natriuretic peptides (NT-proBNP), reduced left ventricular ejection fraction, and positive cardiac tropo

Interactive worksheet

TWILIGHT-HF Subgroup Analysis Score

Exploratory : Explanation and context The TWILIGHT randomized trial tested whether, among high-risk patients who had completed 3 months of dual antiplatelet therapy after PCI, stopping aspirin and continuing ticagrelor monotherapy reduced clinically relevant bleeding without increasing ischemic events. The trial found a lower rate of BARC 2/3/5 bleeding with ticagrelor monotherapy versus ticagrelor plus aspirin, with